Harpoon Therapeutics Investor Relations Material
Latest events
Study Update
Harpoon Therapeutics
Corporate Presentation
1 Dec, 2023
Q3 2023
9 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Harpoon Therapeutics Inc
Access all reports
Harpoon Therapeutics Inc. is a clinical-stage immunotherapy company engaged in the development of innovative T cell engagers. These engagers are designed to harness the power of the body's immune system to treat patients suffering from cancer and other diseases.The company is headquartered in South San Francisco, California, and its shares are listed on the Nasdaq.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
HARP
Country
🇺🇸 United States